The Renaissance IPO ETF ( IPO) share price has recovered to levels not seen since early February, reflecting a modest revival ...

OmniAb's reliance on licensing transgenic animals for drug discovery faces risks with FDA shifts and cash burn issues. Learn ...

Match Group's global presence and diverse product portfolio position it better than Bumble. Click here to see why MTCH stock ...

Omada, which offers chronic condition management programs, is following in the footsteps of Hinge Health to become the latest ...